{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:12:26Z","timestamp":1768734746774,"version":"3.49.0"},"reference-count":36,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100006261","name":"Taif University Researchers Supporting Project","doi-asserted-by":"publisher","award":["TURSP-2020\/103"],"award-info":[{"award-number":["TURSP-2020\/103"]}],"id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Chia seed is an oil-seed of multiple biological activities. Doxorubicin is an effective chemotherapy for liver cancer. Resistance and adverse effects are doxorubicin limitations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to investigate the effect of chia seeds oil (CSO) on the resistance of HepG2 cells to liposomal-doxorubicin (DOX).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The objective were investigated through measuring cytotoxicity, doxorubicin-metabolizing enzyme Cytochrome P450 3A4 (CYP-3A4), multidrug resistance-associated protein (MRP1), and the expression of multiple tumor suppressor microRNAs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The findings indicated that low concentration of CSO increased HepG2 cells sensitivity to DOX as concluded from its higher cytotoxicity. DOX induced mRNAs of CYP-3A4 and MRP1 and their protein levels. CSO inhibited both in DOX-treated cells. CSO induced tumor suppressor miRNAs. Doxorubicin inhibited miR-122 and let-7\/b\/e expression, while it led to overexpression of let-7a. CSO\/DOX upregulated let-7\/b\/e, miR-34a, and miR-122 (which inhibits MRP1) and downregulated let-7a that may lead to increased apoptosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>CSO effectively re-sensitized HepG2 cells to liposomal-doxorubicin via inhibiting MRP1 and CYP-3A4 that may increase in vivo doxorubicin bioavailability and decrease its therapeutic dose to diminish its adverse effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201023666220921125258","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:29:43Z","timestamp":1663907383000},"page":"570-578","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chia Seeds Oil Suppresses the Resistance of Hepatocellular Carcinoma\nCells to Liposomal-doxorubicin and Upregulates the Tumor Suppressor\nmiRNAs"],"prefix":"10.2174","volume":"24","author":[{"given":"Els T.","family":"Awad","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Cairo\nUniversity, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaimaa A.","family":"Tawfik","sequence":"additional","affiliation":[{"name":"Biochemistry Department, National Research Centre, 33 El Buhouth St., Dokki, 12622, Giza, Egypt"},{"name":"Cancer Biology\nand Genetics Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, 33 El Buhouth St.\nDokki, 12622, Giza, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda O.","family":"Abu Bakr","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Cairo\nUniversity, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail M.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Cairo\nUniversity, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmat","family":"Ashour","sequence":"additional","affiliation":[{"name":"Biochemistry Department, National Research Centre, 33 El Buhouth St., Dokki, 12622, Giza, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira M.","family":"Gamal-Eldeen","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Sciences Department, College of Applied Medical Sciences, Taif\nUniversity, P.O. Box 11099, Taif, 21944, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"123","volume":"68","author":"Marcinek K.","year":"2017","unstructured":"Marcinek K.; Krejpcio Z.; Chia seeds (Salvia hispanica): Health promoting properties and therapeutic applications \u2013 a review. Rocz Panstw Zakl Hig 2017,68(2),123-129","journal-title":"Rocz Panstw Zakl Hig"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"13239","DOI":"10.18697\/ajfand.81.17635","volume":"18","author":"Kibui A.N.","year":"2018","unstructured":"Kibui A.N.; Owaga E.; Mburu M.; Proximate composition and nutritional characterization of chia enriched yoghurt. Afr J Food Agric Nutr Dev 2018,18(1),13239-13253","journal-title":"Afr J Food Agric Nutr Dev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13197-015-1967-0","volume":"5","author":"Katunzi-Kilewela A.","year":"2021","unstructured":"Katunzi-Kilewela A.; Kaale L.D.; Kibazohi O.; Rweyemamu L.M.P.; Nutritional, health benefits and usage of chia seeds (Salvia hispanica): A review. Afr J Food Sci 2021,5,48-59","journal-title":"Afr J Food Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.12691\/jfnr-2-5-9","volume":"2","author":"Silveira Coelho M.","year":"2014","unstructured":"Silveira Coelho M.; de las Mercedes Salas-Mellado M.; Chemical characterization of chia (Salvia hispanica L.) for use in food products. J Food Nutr Res 2014,2(5),263-269","journal-title":"J Food Nutr Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s13197-015-1967-0","volume":"53","author":"Ullah R.","year":"2016","unstructured":"Ullah R.; Nadeem M.; Khalique A.; Imran M.; Mehmood S.; Javid A.; Hussain J.; Nutritional and therapeutic perspectives of Chia (Salvia hispanica L.): A review. J Food Sci Technol 2016,53(4),1750-1758","journal-title":"J Food Sci Technol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.foodchem.2017.04.002","volume":"232","author":"Oliveira-Alves S.C.","year":"2017","unstructured":"Oliveira-Alves S.C.; Vendramini-Costa D.B.; Betim Cazarin C.B.; Mar&#xF3;stica J&#xFA;nior M.R.; Borges Ferreira J.P.; Silva A.B.; Prado M.A.; Bronze M.R.; Characterization of phenolic compounds in chia (Salvia hispanica L.) seeds, fiber flour and oil. Food Chem 2017,232(33),295-305","journal-title":"Food Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"108106030","DOI":"10.1016\/j.foodhyd.2020.106030","author":"Di Marco A.E.","year":"2020","unstructured":"Di Marco A.E.; Ixtaina V.Y.; Tom&#xE1;s M.C.; Inclusion complexes of high amylose corn starch with essential fatty acids from chia seed oil as potential delivery systems in food. Food Hydrocoll 2020,108106030","journal-title":"Food Hydrocoll"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"71104026","DOI":"10.1016\/j.jff.2020.104026","author":"Enes B.N.","year":"2020","unstructured":"Enes B.N.; Moreira L.P.D.; Toledo R.C.L.; Moraes &#xC9;.A.; Moreira M.E.C.; Hermsdorff H.H.M.; Noratto G.; Mertens-Talcott S.U.; Talcott S.; Martino H.S.D.; Effect of different fractions of chia (Salvia hispanica L.) on glucose metabolism, in vivo and in vitro. J Funct Foods 2020,71104026","journal-title":"J Funct Foods"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"127531","DOI":"10.1016\/j.foodchem.2020.127531","volume":"333","author":"Ghafoor K.","year":"2020","unstructured":"Ghafoor K.; Ahmed I.A.M.; &#xD6;zcan M.M.; Al-Juhaimi F.Y.; Babiker E.E.; Azmi I.U.; An evaluation of bioactive compounds, fatty acid composition and oil quality of chia (Salvia hispanica L.) seed roasted at different temperatures. Food Chem 2020,333,127531","journal-title":"Food Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/gels5020019","volume":"5","author":"Mu&#xF1;oz-Gonz&#xE1;lez I.","year":"2019","unstructured":"Mu&#xF1;oz-Gonz&#xE1;lez I.; Merino-&#xC1;lvarez E.; Salvador M.; Pintado T.; Ruiz-Capillas C.; Jim&#xE9;nez-Colmenero F.; Herrero A.M.; Chia (Salvia hispanica L.) a promising alternative for conventional and gelled emulsions: technological and lipid structural characteristics. Gels 2019,5(2),19","journal-title":"Gels"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"238873","DOI":"10.22161\/ijeab\/2.4.61","volume":"2","author":"Attalla N.R.","year":"2017","unstructured":"Attalla N.R.; El-Hussieny E.A.; Characteristics of nutraceutical yoghurt mousse fortified with chia seeds. Int J Environ Agri Biotechnol 2017,2,238873","journal-title":"Int J Environ Agri Biotechnol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5599\/admet.1.3.7","volume":"1","author":"Tam K.","year":"2013","unstructured":"Tam K.; The roles of doxorubicin in hepatocellular carcinoma. ADMET DMPK 2013,1(3),29-44","journal-title":"ADMET DMPK"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.repbio.2019.02.004","volume":"19","author":"Renu K.","year":"2019","unstructured":"Renu K.; Valsala Gopalakrishnan A.; Deciphering the molecular mechanism during doxorubicin-mediated oxidative stress, apoptosis through Nrf2 and PGC-1&#x3B1; in a rat testicular milieu. Reprod Biol 2019,19(1),22-37","journal-title":"Reprod Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejphar.2018.11.018","volume":"843","author":"Renu K.","year":"2019","unstructured":"Renu K.; K B, S.; Parthiban, S.; S, S.; George, A.; P B, T.P.; Suman, S.; v G, A.; Arunachalam, S. Elevated lipolysis in adipose tissue by doxorubicin via PPAR&#x3B1; activation associated with hepatic steatosis and insulin resistance. Eur J Pharmacol 2019,843,162-176","journal-title":"Eur J Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","volume":"818","author":"Kaviyarasi R.","year":"2018","unstructured":"Kaviyarasi R.; Abilash V.G.; Tirupathi P.P.B.; Sankarganesh A.; Molecular mechanism of doxorubicin-induced cardiomyopathy-An update. Eur J Pharmacol 2018,818,241-253","journal-title":"Eur J Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.taap.2012.03.012","volume":"261","author":"Henninger C.","year":"2012","unstructured":"Henninger C.; Huelsenbeck J.; Huelsenbeck S.; Gr&#xF6;sch S.; Schad A.; Lackner K.J.; Kaina B.; Fritz G.; The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity. Toxicol Appl Pharmacol 2012,261(1),66-73","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"117599","DOI":"10.1016\/j.lfs.2020.117599","volume":"250","author":"Prasanna P.L.","year":"2020","unstructured":"Prasanna P.L.; Renu K.; Valsala G.A.; New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sci 2020,250,117599","journal-title":"Life Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","volume":"119","author":"Hansen M.B.","year":"1989","unstructured":"Hansen M.B.; Nielsen S.E.; Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill. J Immunol Methods 1989,119,203-210","journal-title":"J Immunol Methods"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"Chou T.C.","year":"1984","unstructured":"Chou T.C.; Talalay P.; Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984,22,27-55","journal-title":"Adv Enzyme Regul"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"Livak K.J.","year":"2001","unstructured":"Livak K.J.; Schmittgen T.D.; Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method Methods 2001,25,402-408","journal-title":"Method Methods"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/hep.15.41","volume":"3","author":"Cox J.","year":"2016","unstructured":"Cox J.; Weinman S.; Mechanisms of doxorubicin resistance in hepatocellular carcinoma. Hepat Oncol 2016,3(1),57-59","journal-title":"Hepat Oncol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","volume":"15","author":"Speth P.A.J.","year":"1988","unstructured":"Speth P.A.J.; van Hoesel Q.G.C.M.; Haanen C.; Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet 1988,15(1),15-31","journal-title":"Clin Pharmacokinet"},{"key":"ref=23","first-page":"87","volume":"105","author":"Lee H.J.","year":"1999","unstructured":"Lee H.J.; Lee M.G.; Effects of dexamethasone on the pharmacokinetics of adriamycin after intravenous administration to rats. Res Commun Mol Pathol Pharmacol 1999,105(1-2),87-96","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12272-011-0411-x","volume":"34","author":"Choi J.S.","year":"2011","unstructured":"Choi J.S.; Piao Y.J.; Kang K.W.; Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 2011,34(4),607-613","journal-title":"Arch Pharm Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1309\/AC1M-4TY4-U0TN-EN7T","volume":"113","author":"Ng I.O.L.","year":"2000","unstructured":"Ng I.O.L.; Liu C.L.; Fan S.T.; Ng M.; Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol 2000,113(3),355-363","journal-title":"Am J Clin Pathol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ijc.1498","volume":"94","author":"Nies A.T.","year":"2001","unstructured":"Nies A.T.; K&#xF6;nig J.; Pfannschmidt M.; Klar E.; Hofmann W.J.; Keppler D.; Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer 2001,94(4),492-499","journal-title":"Int J Cancer"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1158\/0008-5472.CAN-08-4315","volume":"69","author":"Solazzo M.","year":"2009","unstructured":"Solazzo M.; Fantappi&#xE8; O.; D\u2019Amico M.; Sassoli C.; Tani A.; Cipriani G.; Bogani C.; Formigli L.; Mazzanti R.; Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res 2009,69(18),7235-7242","journal-title":"Cancer Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1073\/pnas.84.9.3004","volume":"84","author":"Ueda K.","year":"1987","unstructured":"Ueda K.; Cardarelli C.; Gottesman M.M.; Pastan I.; Expression of a full-length cDNA for the human &#x201C;MDR1&#x201D; gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci 1987,84(9),3004-3008","journal-title":"Proc Natl Acad Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2010.07.049","volume":"140","author":"Cheung S.T.","year":"2011","unstructured":"Cheung S.T.; Cheung P.F.Y.; Cheng C.K.C.; Wong N.C.L.; Fan S.T.; Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 2011,140(1),344-355.e2","journal-title":"Gastroenterology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1046\/j.1440-1746.2001.02457.x","volume":"16","author":"Shiraga K.","year":"2001","unstructured":"Shiraga K.; Sakaguchi K.; Senoh T.; Ohta T.; Ogawa S.; Sawayama T.; Mouri H.; Fujiwara A.; Tsuji T.; Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines. J Gastroenterol Hepatol 2001,16(4),460-466","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"Bartel D.P.","year":"2004","unstructured":"Bartel D.P.; MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004,116,281-291","journal-title":"Cell"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1038\/onc.2013.492","volume":"33","author":"Sun X.","year":"2014","unstructured":"Sun X.; Jiao X.; Pestell T.G.; Fan C.; Qin S.; Mirabelli E.; Ren H.; Pestell R.G.; MicroRNAs and cancer stem cells: The sword and the shield. Oncogene 2014,33(42),4967-4977","journal-title":"Oncogene"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10495-008-0256-z","volume":"13","author":"Tsang W.P.","year":"2008","unstructured":"Tsang W.P.; Kwok T.T.; Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 2008,13(10),1215-1222","journal-title":"Apoptosis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2011.06.027","volume":"310","author":"Xu Y.","year":"2011","unstructured":"Xu Y.; Xia F.; Ma L.; Shan J.; Shen J.; Yang Z.; Liu J.; Cui Y.; Bian X.; Bie P.; Qian C.; MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett 2011,310(2),160-169","journal-title":"Cancer Lett"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1074\/jbc.M114.601203","volume":"290","author":"Wu Q.","year":"2015","unstructured":"Wu Q.; Liu H.O.; Liu Y.D.; Liu W.S.; Pan D.; Zhang W.J.; Yang L.; Fu Q.; Xu J.J.; Gu J.X.; Decreased expression of hepatocyte nuclear factor 4&#x3B1; (Hnf4&#x3B1;)\/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity. J Biol Chem 2015,290(2),1170-1185","journal-title":"J Biol Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12012-021-09644-3","volume":"21","author":"Ahmed A.Z.","year":"2021","unstructured":"Ahmed A.Z.; Mumbrekar K.D.; Satyam S.M.; Shetty P.; D\u2019Souza M.R.; Singh V.K.; Chia seed oil ameliorates doxorubicin-induced cardiotoxicity in female wistar rats: An electrocardiographic, biochemical and histopathological approach. Cardiovasc Toxicol 2021,21(7),533-542","journal-title":"Cardiovasc Toxicol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220921125258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209023\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220921125258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:13:57Z","timestamp":1683112437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209023\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201023666220921125258","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}